1 Min Read
Sept 26 (Reuters) - Verseon Corp
* Verseon Corp says announced launch of a drug program developing oral treatments for hereditary angioedema Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.